BioCentury
ARTICLE | Clinical News

Theelin estrone injectable suspension regulatory update

December 24, 2001 8:00 AM UTC

KG will withdraw its NDA for Theelin to treat moderate to severe vasomotor symptoms of menopause and vaginal and vulvar atrophy. KG said the FDA requested additional clinical trials and bioavailabilit...